Home / Companies / Upm Pharmaceuticals / Trends
Upm Pharmaceuticals H-1B trends
Quarterly LCA aggregate trend points for Upm Pharmaceuticals. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Upm Pharmaceuticals span 2016 Q2 to 2021 Q3, peaking at 4 filings in 2017 Q2.
The most recent reported period (2021 Q3) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2016 Q2 | 3 | 3 | 3 | $64,639 | $64,390 | 3 | 100.0% |
| 2017 Q2 | 4 | 3 | 3 | $62,500 | $60,367 | 4 | 100.0% |
| 2018 Q2 | 4 | 3 | 2 | $72,530 | $71,729 | 4 | 100.0% |
| 2020 Q1 | 2 | 2 | 2 | $82,611 | $82,524 | 2 | 100.0% |
| 2020 Q2 | 1 | 1 | 1 | $108,300 | $108,222 | 1 | 100.0% |
| 2020 Q4 | 1 | 1 | 1 | $63,211 | $63,211 | 1 | 100.0% |
| 2021 Q3 | 1 | 1 | 1 | $63,211 | $63,211 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Upm Pharmaceuticals changed over time?
- H-1B LCA filings for Upm Pharmaceuticals span 2016 Q2 to 2021 Q3, peaking at 4 filings in 2017 Q2. The most recent reported period (2021 Q3) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=upm+pharmaceuticals&metric=lca_countJSON